Stock Themes
Baskets long-term investors actually talk about — with metrics & a 5-year forecast.
Magnificent SevenBig Chip — SemiconductorsUndervaluedGrowthTop Dividend StocksRecession-ProofReal Estate (REITs)Best HealthcareBest Oil & Energy
Magnificent Seven
- The seven mega-cap technology companies — Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla — that together drive a large share of the entire S&P 500's return.
- If you own an index fund you already own a lot of these, so knowing them helps you understand what's really moving your portfolio.
- Huge cash flows and wide moats, but real concentration risk — when these few names fall, the whole market tends to follow.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| AAPLApple Inc. | $297.01 | 35.6x | 146.7% | 12.8% | 22–31%/yr |
| MSFTMicrosoft Corporation | $367.34 | 22.5x | 33.1% | 17.9% | 22–32%/yr |
| GOOGLAlphabet Inc. | $349.68 | 27.8x | 39.0% | 17.4% | 27–38%/yr |
| AMZNAmazon.com, Inc. | $232.79 | 29.2x | 23.3% | 14.2% | 27–38%/yr |
| NVDANVIDIA Corporation | $208.65 | 32.2x | 111.7% | 70.7% | 27–38%/yr |
| METAMeta Platforms, Inc. | $563.85 | 20.8x | 33.2% | 26.2% | 1–10%/yr |
| TSLATesla, Inc. | $405.05 | 110x | 4.8% | 2.3% | -15–-8%/yr |
Big Chip — Semiconductors
- The companies that design and manufacture the chips behind AI, phones, cars, and data centers.
- A long-term, pick-and-shovel way to own the growth of technology broadly instead of betting on a single end-product.
- Powerful secular demand, but the industry is cyclical — expect boom-and-bust swings around supply and demand.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| NVDANVIDIA Corporation | $208.65 | 32.2x | 111.7% | 70.7% | 27–38%/yr |
| AVGOBroadcom Inc. | $392.13 | 66.8x | 36.4% | 32.3% | 27–38%/yr |
| AMDAdvanced Micro Devices, Inc. | $551.63 | 174.9x | 8.1% | 35.0% | 27–38%/yr |
| QCOMQualcomm | $221.90 | 24.3x | 40.2% | 5.2% | -12–-5%/yr |
| TXNTexas Instruments | $332.28 | 55.5x | 32.5% | 14.9% | 5–13%/yr |
| MUMicron Technology | $1211.38 | 54.2x | 40.8% | 85.5% | 27–38%/yr |
| AMATApplied Materials | $640.18 | 58.5x | 39.8% | 3.3% | 22–32%/yr |
Undervalued
Auto-updated- Companies trading at low earnings multiples relative to their profitability — potential bargains the market may be overlooking.
- Value investing is a long-term bet that price eventually catches up to fundamentals; it rewards patience.
- Beware “value traps” — cheap can stay cheap, so this list pairs a low P/E with real quality (healthy ROE and positive margins).
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| UHSUniversal Health Services | $142.64 | 5.5x | 21.0% | 10.4% | 27–37%/yr |
| EXEExpand Energy | $88.44 | 6.4x | 17.4% | 170.6% | -15–-8%/yr |
| ACGLArch Capital Group | $92.04 | 6.5x | 20.5% | 7.8% | 26–36%/yr |
| EGEverest Group | $339.30 | 6.6x | 13.3% | -0.6% | 27–38%/yr |
| SYFSynchrony Financial | $75.71 | 7.1x | 21.4% | 20.5% | 25–35%/yr |
| TAT&T | $22.10 | 7.2x | 19.7% | 2.9% | 27–38%/yr |
| EIXEdison International | $72.20 | 7.4x | 22.0% | 13.2% | 20–29%/yr |
| FISFidelity National Information Services | $37.72 | 7.4x | 18.4% | 12.2% | 27–38%/yr |
Growth
Auto-updated- Companies growing revenue quickly and reinvesting for the future rather than paying large dividends.
- Compounding revenue over many years can drive outsized long-term returns.
- The risk is overpaying — valuations are high, so the growth has to actually show up to justify the price.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| STTState Street Corporation | $173.71 | 15.3x | 11.1% | 181.2% | 5–14%/yr |
| EXEExpand Energy | $88.44 | 6.4x | 17.4% | 170.6% | -15–-8%/yr |
| JPMJPMorgan Chase & Co. | $331.48 | 14.8x | 16.3% | 109.0% | -3–4%/yr |
| BACBank of America | $57.37 | 12.6x | 10.5% | 99.4% | 12–21%/yr |
| CCitigroup | $145.67 | 15.1x | 7.5% | 99.2% | 19–29%/yr |
| MTBM&T Bank | $227.73 | 11.2x | 10.3% | 86.2% | 13–22%/yr |
| MUMicron Technology | $1211.38 | 54.2x | 40.8% | 85.5% | 27–38%/yr |
| USBU.S. Bancorp | $58.68 | 11.3x | 12.2% | 84.1% | 10–19%/yr |
Top Dividend Stocks
Auto-updated- Companies that pay you a slice of their profits in cash every year — income you receive without ever selling a share.
- For long-term investors, reinvested dividends have historically driven a large share of the stock market's total return.
- Watch for “yield traps”: an unusually high yield can signal a struggling business, so this list favours large, profitable payers. The Div Yield column is each stock's annual income return.
| Stock | Price | Div Yield | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|---|
| UPSUnited Parcel Service | $107.24 | 6.6% | 17x | 33.0% | -2.9% | -15–-8%/yr |
| PFEPfizer | $25.08 | 6.6% | 19.1x | 8.4% | 1.4% | -11–-3%/yr |
| VICIVici Properties | $26.09 | 6.2% | 9.3x | 11.2% | 4.1% | 10–18%/yr |
| MOAltria | $69.51 | 6.1% | 14.3x | 149.7% | -1.1% | -15–-8%/yr |
| VZVerizon | $45.36 | 5.9% | 11x | 16.7% | 2.9% | -8–-1%/yr |
| CMCSAComcast | $22.32 | 5.5% | 4.2x | 19.8% | 1.4% | 18–27%/yr |
| ORealty Income | $60.58 | 5.2% | 50.1x | 2.9% | 9.8% | 3–11%/yr |
| PRUPrudential Financial | $108.26 | 5.2% | 10.7x | 10.9% | 3.9% | 27–38%/yr |
| KMBKimberly-Clark | $100.50 | 5.0% | 16x | 143.6% | -16.2% | -15–-8%/yr |
| OKEOneok | $86.29 | 4.9% | 15.1x | 15.9% | -14.7% | 3–11%/yr |
Recession-Proof
- Businesses selling what people buy in good times and bad — food, drinks, household staples, and basic healthcare.
- Their earnings hold up better in downturns, so they tend to fall less than the market when the economy weakens.
- The trade-off is slower growth in boom times — these are portfolio ballast, not rockets.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| PGThe Procter & Gamble Company | $147.68 | 21x | 31.2% | 3.3% | 3–11%/yr |
| KOThe Coca-Cola Company | $79.53 | 25.1x | 43.6% | 5.1% | 20–30%/yr |
| PEPPepsiCo, Inc. | $140.71 | 22.2x | 43.9% | 4.3% | -12–-5%/yr |
| WMTWalmart | $117.18 | 41x | 23.9% | 5.9% | 15–24%/yr |
| COSTCostco Wholesale Corporation | $951.35 | 48x | 28.3% | 9.2% | 6–15%/yr |
| MCDMcDonald's | $270.10 | 22.8x | 95.1% | 6.8% | 1–9%/yr |
| JNJJohnson & Johnson | $231.29 | 26.1x | 26.3% | 7.9% | -9–-2%/yr |
| MDLZMondelez International | $59.51 | 29.2x | 10.1% | 7.8% | -15–-8%/yr |
| CLColgate-Palmolive | $88.67 | 34.6x | 475.1% | 4.3% | -15–-8%/yr |
| WMWaste Management | $213.31 | 30.6x | 28.9% | 10.9% | -2–6%/yr |
Real Estate (REITs)
- REITs own income-producing property — data centers, warehouses, cell towers, apartments, and malls — and must pay out most of their profits as dividends.
- A way to earn real-estate income without being a landlord, usually with above-average dividend yields.
- Interest-rate sensitive: higher rates raise their borrowing costs and make their yields less competitive.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| AMTAmerican Tower | $176.43 | 28.2x | 78.2% | 6.3% | 27–38%/yr |
| PLDPrologis | $143.83 | 36.1x | 7.0% | 6.7% | -7–1%/yr |
| EQIXEquinix | $1115.94 | 73.7x | 10.0% | 6.7% | 27–38%/yr |
| WELLWelltower | $211.45 | 103.6x | 3.5% | 37.5% | 9–18%/yr |
| DLRDigital Realty | $195.54 | 47.5x | 6.0% | 12.6% | 27–38%/yr |
| PSAPublic Storage | $320.22 | 29.4x | 20.5% | 2.9% | -9–-2%/yr |
| ORealty Income | $60.58 | 50.1x | 2.9% | 9.8% | 3–11%/yr |
| SPGSimon Property Group | $214.57 | 14.6x | 126.3% | 10.9% | 27–38%/yr |
| CCICrown Castle | $83.12 | 33.8x | 21.0% | -29.6% | -15–-8%/yr |
| VICIVici Properties | $26.09 | 9.3x | 11.2% | 4.1% | 10–18%/yr |
Best Healthcare
- Drugmakers, insurers, and device makers serving demand that doesn't disappear in a recession.
- An aging population and steady medical innovation give the sector a long-term tailwind.
- Watch drug-pricing and policy risk, plus patent expirations that can dent any single company.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| LLYLilly (Eli) | $1102.08 | 41.1x | 101.3% | 47.4% | 27–38%/yr |
| UNHUnitedHealth Group Incorporated | $406.68 | 30.3x | 12.4% | 9.7% | -15–-8%/yr |
| JNJJohnson & Johnson | $231.29 | 26.1x | 26.3% | 7.9% | -9–-2%/yr |
| MRKMerck & Co. | $115.48 | 31.4x | 17.9% | 2.9% | -15–-8%/yr |
| ABBVAbbVie | $230.01 | 104.4x | 95.6% | 9.5% | -15–-8%/yr |
| TMOThermo Fisher Scientific | $464.01 | 25.4x | 13.2% | 5.4% | 1–9%/yr |
| ABTAbbott Laboratories | $87.83 | 24.5x | 12.2% | 6.6% | -15–-8%/yr |
| AMGNAmgen | $344.72 | 23.5x | 89.4% | 9.1% | 24–34%/yr |
| PFEPfizer | $25.08 | 19.1x | 8.4% | 1.4% | -11–-3%/yr |
| ISRGIntuitive Surgical | $402.95 | 48.7x | 17.0% | 21.4% | 14–23%/yr |
Best Oil & Energy
- Companies that find, produce, refine, and transport the oil and gas still powering the global economy.
- Often strong dividend payers and a useful hedge against inflation and energy-price spikes.
- Cyclical and volatile — profits swing with commodity prices, and the long-term energy transition is a real risk.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| XOMExxon Mobil Corporation | $138.47 | 22.4x | 9.8% | -4.1% | -15–-8%/yr |
| CVXChevron Corporation | $175.06 | 31.3x | 6.2% | -3.6% | -15–-8%/yr |
| COPConocoPhillips | $109.70 | 17.8x | 11.3% | 1.4% | -15–-8%/yr |
| EOGEOG Resources | $132.83 | 12.6x | 18.3% | 2.7% | -11–-4%/yr |
| SLBSchlumberger | $47.95 | 21.6x | 13.6% | -0.4% | -15–-8%/yr |
| PSXPhillips 66 | $168.41 | 16.1x | 14.7% | -2.4% | 27–38%/yr |
| MPCMarathon Petroleum | $247.29 | 15.1x | 27.3% | -0.9% | 27–38%/yr |
| OXYOccidental Petroleum | $52.00 | 10.9x | 12.9% | -8.0% | 27–38%/yr |
| WMBWilliams Companies | $74.95 | 32x | 22.0% | 10.7% | 15–24%/yr |
| KMIKinder Morgan | $32.25 | 21.2x | 10.7% | 13.1% | 21–31%/yr |
Educational stock baskets, not investment advice or a recommendation to buy, hold, or sell any security. The 5-year forecast is an illustrative projection (it grows current earnings by recent growth and applies a steady-to-compressed P/E), not a prediction. Do your own research and consult a licensed professional.